Changting Li

Changting Li is a highly experienced cell biologist with a specialization in immunology, boasting a decade of dedicated expertise in lipid-related preclinical drug development. Profound knowledge in specific lipid-controlled receptor signaling activation, with a remarkable track record of accomplishments. He has analysed the role of specific lipids in T-cell activation, persistence of JAK-STAT signaling (Cytokines) and PDL1 degradation, resulting in three key publications as the first author featured in prestigious journals (Nature Communications, PNAS and etc.) and two presentations at international lipid conferences.